A research study in Uganda to test a Family Involvement intervention, designed to improved care for people living in the community with severe mental illness
Not Applicable
Completed
- Conditions
- Patients with severe mental illness (including psychosis)Mental and Behavioural Disorders
- Registration Number
- ISRCTN78948497
- Lead Sponsor
- Queen Mary University of London
- Brief Summary
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31200671/ (added 24/09/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 118
Inclusion Criteria
1. Patients with a primary diagnosis of severe mental illness (ICD-10 F20-29, F31, F32)
2. Aged 18-65 years
3. Capacity to provide informed consent assessed by UBACC Score of =14;
4. Able to communicate in Luganda or English
5. Can identify a family member or friend
6. Scores 5 or below on the MANSA scale
Exclusion Criteria
1. Primary diagnosis of substance-use disorder; organic psychosis and/or neurocognitive disorder
2. Currently an inpatient at the time of recruitment
3. Participating in another study conducted by this or another research group
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life measured using the Manchester Short Assessment of Quality of Life (MANSA) at baseline, 6 and 12 months
- Secondary Outcome Measures
Name Time Method <br> 1. Objective social functioning, measured using Objective Social Outcome Index (SIX) at baseline, 6 and 12 months<br> 2. Symptoms, measured using Brief Psychiatric Rating Scale (BPRS) at baseline, 6 and 12 months<br> 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline, 6 and 12 months<br> 4. Stigma, measured using the Internalized Stigma of Mental Illness Inventory (ISMI) at baseline, 6 and 12 months<br> 5. Medication adherence, measures using the Medication Adherence Rating Scale (MARS) at baseline, 6 months and 12 months<br>